Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

被引：0
|
作者：
Hu, Bei [1 ]
Korsos, Victoria [2 ]
Palomba, M. Lia [2 ,3 ]
机构：
[1] Wake Forest Sch Med, Atrium Hlth Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC 28202 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
chimeric antigen receptor T cell therapy (CAR T cell therapy); diffuse large B cell lymphoma (DLBCL); high grade B cell lymphoma; mantle cell lymphoma (MCL); relapsed and refractory lymphoma; CENTRAL-NERVOUS-SYSTEM; AXICABTAGENE CILOLEUCEL; COST-EFFECTIVENESS; BREXUCABTAGENE AUTOLEUCEL; PREDICTIVE FACTORS; OUTCOMES; MULTICENTER; INFLAMMATION; PERSISTENCE; IBRUTINIB;
D O I：
10.3389/fonc.2024.1394057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell lymphoma and mantle cell lymphoma, highlighting their efficacy and toxicity as well as discussing future directions.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [2] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
    Manzar, Gohar S.
    Pinnix, Chelsea C.
    Dudzinski, Stephanie O.
    Marqueen, Kathryn E.
    Cha, Elaine E.
    Nasr, Lewis F.
    Yoder, Alison K.
    Rooney, Michael K.
    Strati, Paolo
    Ahmed, Sairah
    Nze, Chijioke
    Nair, Ranjit
    Fayad, Luis E.
    Wang, Michael
    Nastoupil, Loretta J.
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Dabaja, Bouthaina S.
    Wu, Susan Y.
    Fang, Penny Q.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2561 - 2567
  • [4] Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products
    Hunter, Bradley D.
    Rogalski, Michael
    Jacobson, Caron A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1157 - 1164
  • [5] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
    Anagha Deshpande
    William Rule
    Allison Rosenthal
    Current Treatment Options in Oncology, 2022, 23 : 89 - 98
  • [6] Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas
    Shengnan Ding
    Xia Mao
    Yang Cao
    Na Wang
    Hao Xu
    Jianfeng Zhou
    Targeted Oncology, 2020, 15 : 365 - 375
  • [7] Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas
    Ding, Shengnan
    Mao, Xia
    Cao, Yang
    Wang, Na
    Xu, Hao
    Zhou, Jianfeng
    TARGETED ONCOLOGY, 2020, 15 (03) : 365 - 375
  • [8] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
    Deshpande, Anagha
    Rule, William
    Rosenthal, Allison
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 89 - 98
  • [9] Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas
    Di, Mengyang
    Potnis, Kunal C.
    Long, Jessica B.
    Isufi, Iris
    Foss, Francine
    Seropian, Stuart
    Gross, Cary P.
    Huntington, Scott F.
    JNCI CANCER SPECTRUM, 2024, 8 (04)
  • [10] Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas
    Dodero, Anna
    Bramanti, Stefania
    Di Trani, Martina
    Pennisi, Martina
    Ljevar, Silva
    Chiappella, Annalisa
    Massimo, Magagnoli
    Guidetti, Anna
    Corrado, Francesco
    Nierychlewska, Paulina Maria
    Di Rocco, Alice
    Lorenzini, Daniele
    Daoud, Rahal
    De Philippis, Chiara
    Santoro, Armando
    Carlo-Stella, Carmelo
    Corradini, Paolo
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (01) : 151 - 159
12345